Keywords: COVID-19; SARS-coV-2; SRAS-CoV-2; anti-inflammatory medications; anti-microbial stewardship; anti-viral therapy; gestion des antimicrobiens; médicaments anti-inflammatoires; recommandations thérapeutiques; traitement antiviral; treatment recommendations.